US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BLACKSTONE STRATEGIC CREDIT 2027 TERM FUND

11.61

0.0000

Post-market: 11.610.00000.00%16:10 EST

Volume:162.44K

Turnover:1.89M

Market Cap:518.55M

PE:-8.58

High:11.67

Open:11.64

Low:11.58

Close:11.61

52wk High:12.65

52wk Low:10.47

Shares:44.66M

Float Shares:- -

Volume Ratio:1.03

T/O Rate:- -

Dividend:1.01

Dividend Rate:8.71%

EPS(TTM):-1.3539

ROE:--

ROA:--

PB:0.92

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

BeiGene’s BGB-24714 Solid Tumor Trial Terminated: What It Means for Oncology Investors

Bitget is about to launch the 15th Contract Trading Club Competition, with a total prize pool of 50,000 BGB.

BeiGene’s Innovative Study on BGB-53038: A Potential Game-Changer in Cancer Treatment

BeiGene’s BGB-16673 Study: A New Hope for B-Cell Malignancies?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BGB"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BGB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BGB\",,,,,undefined,":{"symbol":"BGB","market":"US","secType":"STK","nameCN":"BLACKSTONE STRATEGIC CREDIT 2027 TERM FUND","latestPrice":11.61,"timestamp":1770670800000,"preClose":11.61,"halted":0,"volume":162440,"hourTrading":{"tag":"盘后","latestPrice":11.61,"preClose":11.61,"latestTime":"16:10 EST","volume":67,"amount":778.38,"timestamp":1770671404223,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0,"floatShares":0,"shares":44664382,"eps":-1.35391,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-09 16:00:00 EST","open":11.64,"high":11.6748,"low":11.58,"amount":1885503.7216,"amplitude":0.008165,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.35391,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770714000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":11.61,"dividendRate":0.08708,"postHourTrading":{"tag":"盘后","latestPrice":11.61,"preClose":11.61,"latestTime":"16:10 EST","volume":67,"amount":778.38,"timestamp":1770671404223,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.030755},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BGB\",,,,,undefined,":{"symbol":"BGB","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.030755,"shares":44664382,"dividePrice":1.011,"high":11.6748,"amplitude":0.008165,"preClose":11.61,"low":11.58,"week52Low":10.47,"pbRate":"0.92","week52High":12.65,"institutionHeld":0,"latestPrice":11.61,"eps":-1.35391,"divideRate":0.08708,"volume":162440,"delay":0,"ttmEps":-1.35391,"open":11.64,"prevYearClose":11.78,"prevWeekClose":11.61,"prevMonthClose":11.78,"prevQuarterClose":11.78,"fiveDayClose":11.77,"twentyDayClose":11.92,"sixtyDayClose":11.81},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BGB\",params:#limit:5,,,undefined,":[{"date":"2026-02-20","symbol":"BGB","amount":0.077,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-20","defaultRemindTime":1771597800000,"name":"BLACKSTONE STRATEGIC CREDIT 2027 TERM FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-27","payableDate":"2026-02-20","currency":"USD","dateTimestamp":1771563600000,"payDate":"2026-02-27"},{"date":"2025-12-31","symbol":"BGB","amount":0.077,"announcedDate":"2025-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-31","defaultRemindTime":1767191400000,"name":"BLACKSTONE STRATEGIC CREDIT 2027 TERM FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-30","payableDate":"2025-12-31","currency":"USD","dateTimestamp":1767157200000,"payDate":"2026-01-30"},{"date":"2025-12-23","symbol":"BGB","amount":0.077,"announcedDate":"2025-12-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"BLACKSTONE STRATEGIC CREDIT 2027 TERM FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-11-20","symbol":"BGB","amount":0.078,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-20","defaultRemindTime":1763649000000,"name":"BLACKSTONE STRATEGIC CREDIT 2027 TERM FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-28","payableDate":"2025-11-20","currency":"USD","dateTimestamp":1763614800000,"payDate":"2025-11-28"},{"date":"2025-10-24","symbol":"BGB","amount":0.078,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-24","defaultRemindTime":1761312600000,"name":"BLACKSTONE STRATEGIC CREDIT 2027 TERM FUND","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-31","payableDate":"2025-10-24","currency":"USD","dateTimestamp":1761278400000,"payDate":"2025-10-31"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BGB\",market:\"US\",,,undefined,":[{"executeDate":"2016-02-18","recordDate":"2016-02-22","paymentDate":"2016-02-29","value":0.105,"currency":"USD"},{"executeDate":"2016-03-21","recordDate":"2016-03-23","paymentDate":"2016-03-31","value":0.105,"currency":"USD"},{"executeDate":"2016-04-20","recordDate":"2016-04-22","paymentDate":"2016-04-29","value":0.105,"currency":"USD"},{"executeDate":"2016-05-19","recordDate":"2016-05-23","paymentDate":"2016-05-31","value":0.105,"currency":"USD"},{"executeDate":"2016-06-21","recordDate":"2016-06-23","paymentDate":"2016-06-30","value":0.105,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BGB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BGB\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606425712","title":"BeiGene’s BGB-24714 Solid Tumor Trial Terminated: What It Means for Oncology Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2606425712","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606425712?lang=en_us&edition=fundamental","pubTime":"2026-01-27 00:30","pubTimestamp":1769445050,"startTime":"0","endTime":"0","summary":"BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines Clinical Study of BGB-24714 Terminated but Still Key fo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beigenes-bgb-24714-solid-tumor-trial-terminated-what-it-means-for-oncology-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beigenes-bgb-24714-solid-tumor-trial-terminated-what-it-means-for-oncology-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","BGB","BK4211"],"gpt_icon":0},{"id":"2578244958","title":"Bitget is about to launch the 15th Contract Trading Club Competition, with a total prize pool of 50,000 BGB.","url":"https://stock-news.laohu8.com/highlight/detail?id=2578244958","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578244958?lang=en_us&edition=fundamental","pubTime":"2025-10-28 19:03","pubTimestamp":1761649380,"startTime":"0","endTime":"0","summary":"BlockBeats News, October 28th, according to official sources, Bitget is about to launch the 15th Contract Trading Club Tournament, with a total prize pool of 50,000 BGB. Users can participate in the Contract Trading Leaderboard Tournament, where they will be ranked based on their cumulative contract trading volume. The top 600 participants will unlock corresponding rewards, with the highest reward being 1,400 BGB per person. The eligible trading pairs for this prize pool include U-based, Coin-based, and USDC contracts.The event is only open to selected users, and detailed rules have been published on the Bitget official platform. Eligible users can click the \"Join Now\" button to complete the registration and participate in the event. The event will take place from October 29th 0:00 to November 4th 23:59:59 .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/318072","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/318072","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BGB"],"gpt_icon":0},{"id":"2578670919","title":"BeiGene’s Innovative Study on BGB-53038: A Potential Game-Changer in Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2578670919","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578670919?lang=en_us&edition=fundamental","pubTime":"2025-10-28 07:36","pubTimestamp":1761608188,"startTime":"0","endTime":"0","summary":"BeOne Medicines (($ONC)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 1a/1b Study to Inve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beigenes-innovative-study-on-bgb-53038-a-potential-game-changer-in-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beigenes-innovative-study-on-bgb-53038-a-potential-game-changer-in-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BGB"],"gpt_icon":0},{"id":"2578918624","title":"BeiGene’s BGB-16673 Study: A New Hope for B-Cell Malignancies?","url":"https://stock-news.laohu8.com/highlight/detail?id=2578918624","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578918624?lang=en_us&edition=fundamental","pubTime":"2025-10-28 01:52","pubTimestamp":1761587539,"startTime":"0","endTime":"0","summary":"BeOne Medicines (($ONC)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Phase 1/2, Open-Label, Do...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beigenes-bgb-16673-study-a-new-hope-for-b-cell-malignancies?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beigenes-bgb-16673-study-a-new-hope-for-b-cell-malignancies?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BGB"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BGB\",params:#limit:6,delay:false,,,undefined,":[]}}